SCHEMBL7867841

SCHEMBL7867841

CC(C)(C)C(=[NH+][O-])c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.55
NR4A2 P43354 2/20 0.54
NR4A1 P22736 1/20 0.54
NR4A3 Q92570 1/20 0.54
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
PTGS1 P23219 1/20 0.51
SLC6A2 P23975 1/20 0.51
CYP2C19 P33261 1/20 0.51
PTGS2 P35354 1/20 0.51
SLC6A3 Q01959 1/20 0.51
HIF1A Q16665 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
PARP10 Q53GL7 1/20 0.51
SRD5A2 P31213 1/20 0.50
PPARG P37231 1/20 0.48
PLA2G4B P0C869 1/20 0.48
EGFR P00533 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15209066 0.80 NQO1 (0.48) PARP10PLA2G4BL3MBTL1ALDH1A1RAB9A
SCHEMBL15189660 0.77 MAOB (0.69) MAOBNR4A2NR4A1NR4A3LMNA
SCHEMBL521489 0.73 NR4A1 (0.72) MAOBNR4A2NR4A1NR4A3LMNA
SCHEMBL7860414 0.73 LMNA (0.51) MAOBNR4A2NR4A1NR4A3LMNA
SCHEMBL339813 0.73 LMNA (0.82) MAOBNR4A2NR4A1NR4A3LMNA
SCHEMBL27367676 0.73 LMNA (0.82) MAOBNR4A2NR4A1NR4A3LMNA
SCHEMBL11603274 0.73 NR4A2 (0.96) MAOBNR4A2NR4A1NR4A3PARP10
SCHEMBL1691467 0.73 MAOB (0.61) MAOBNR4A2NR4A1NR4A3LMNA
SCHEMBL30703555 0.72 MAOB (0.61) MAOBNR4A2NR4A1NR4A3LMNA
SCHEMBL1092594 0.72 NR4A1 (0.70) MAOBNR4A2NR4A1NR4A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077694-A1 ARYL NITRONE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2001-02-28 EP disclosed
WO-1999059576-A1 ARYL NITRONE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 1999-11-25 WO disclosed